Institute of Good Manufacturing Practices India

Global accredited training & certification provider

IGMPI Approvals & Accreditation : Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India, Approved Training Institute of Food Safety and Standards Authority of India (FSSAI), Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India, An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh, Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC)
Trusted by organizations & training participants in over 30 countries. Training | Certification | Education | Research

Adulterated products from Life Rising Corporation seized by FDA officials

14th June 2019

More than 300,000 dietary supplement containers, including tablets, capsules and teas from Life Rising Corporation were seized by the U.S. FDA officials. The products were seized from company’s Willowbrook, Illinois, manufacturing facility, consisted of hundreds of goods bearing brand names Holicare, or Life Rising, and their value is around $3.5 million.

The Illinois District Court determined that the dietary supplements prepared, packed or held by the company were seized due to non-compliance with current good manufacturing practice (cGMP) requirements.

Apart from cGMP violation, the company was also found guilty for not establishing specifications for identity, purity, strength, and composition of finished batches of dietary supplement and for limits on contamination, to ensure product quality. Written procedures for pest control, cleaning and sanitizing equipment were also not available.

Last month, the FDA issued an Administrative Detention Order to prevent these product’s sales until they could be seized. They also issued a safety alert for three Life Rising products due to lead contamination and the company recalled those products.

FDA now discourages consumers from using these products due to recalls, safety alerts and continuous cGMP violations.

For further enquiries, write to or call us on: +91 8587838177, +91 8130924488, 0120-2427175, 0120-4375280

Pharmaceuticals | Food | Clinical Research | Healthcare | Medical Coding | Medical Device | Nanotechnology | IPR

Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like